MAP2K7 and neoplasm: Additionally, lncRNA-orilncl (the genetic target of RAS) was upregulated in BRAF mutant melanoma and promoted tumor cell proliferation and growth by regulating the RAS-RAF-MEK-ERK signaling pathway (75).